Literature DB >> 30883342

Long non-coding RNA MAGI2-AS3 inhibits breast cancer cell migration and invasion via sponging microRNA-374a.

Shanmei Du1,1, Wei Hu2,3,1, Yi Zhao4, Hengzhong Zhou1, Wei Wen1, Miao Xu5, Peiqing Zhao6, Kui Liu3,6.   

Abstract

Long non-coding RNAs (lncRNAs) are non-protein-coding transcripts that play important roles in tumorigenesis and tumor progression. Our study aimed to explore the role of lncRNA MAGI2-AS3 in breast cancer metastatic progression. In the present study, our results showed that MAGI2-AS3 can inhibit the migration and invasion of breast cancer cells. In addition, an increase in MAGI2-AS3 can inhibit microRNA-374a (miR-374a) expression in breast cancer cells. Bioinformatic analysis predicted the correlation between MAGI2-AS3 and miR-374a. Phosphatase and tensin homolog (PTEN) was found to be an novel mRNA target of miR-374a. MAGI2-AS3 upregulation inhibited breast cancer metastatic progression by decreasing miR-374a and enhancing PTEN expression. Together, our data revealed that lncRNA MAGI2-AS3 is involved in breast cancer cell progression by regulating the miR-374a-PTEN axis. These findings offer new insight into treatment strategies for breast cancer.

Entities:  

Keywords:  PTEN; breast cancer; invasion; lncRNA MAGI2-AS3; miR-374a; migration

Mesh:

Substances:

Year:  2019        PMID: 30883342     DOI: 10.3233/CBM-182216

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  16 in total

1.  The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma.

Authors:  Xiulei Zhang; Peiming Zheng; Zhen Li; Shanjun Gao; Guangzhi Liu
Journal:  Onco Targets Ther       Date:  2020-08-04       Impact factor: 4.147

2.  LncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer.

Authors:  Qiuhong Ma; Xiangqin Qi; Xiaona Lin; Liang Li; Libo Chen; Wei Hu
Journal:  Hum Cell       Date:  2019-10-04       Impact factor: 4.174

3.  Long Noncoding MAGI2-AS3 Suppresses Several Cellular Processes of Lung Squamous Cell Carcinoma Cells by Regulating miR-374a/b-5p/CADM2 Axis.

Authors:  Jia He; Xiaoyun Zhou; Li Li; Zhijun Han
Journal:  Cancer Manag Res       Date:  2020-01-15       Impact factor: 3.989

4.  Long Non-Coding RNA MAGI2-AS3 is a New Player with a Tumor Suppressive Role in High Grade Serous Ovarian Carcinoma.

Authors:  Priyanka Gokulnath; Tiziana de Cristofaro; Ichcha Manipur; Tina Di Palma; Amata Amy Soriano; Mario Rosario Guarracino; Mariastella Zannini
Journal:  Cancers (Basel)       Date:  2019-12-12       Impact factor: 6.639

5.  MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis.

Authors:  Hua Chang; Xue Zhang; Baixue Li; Xiangkai Meng
Journal:  Cancer Med       Date:  2020-07-18       Impact factor: 4.452

6.  Construction and Analysis of the Dysregulated ceRNA Network and Identification of Risk Long Noncoding RNAs in Breast Cancer.

Authors:  Xiaojie Su; Zhaoyan Yu; Yuexin Zhang; Jiaxin Chen; Ling Wei; Liang Sun
Journal:  Front Genet       Date:  2021-06-04       Impact factor: 4.599

7.  LncRNA MAGI2-AS3 Is Regulated by BRD4 and Promotes Gastric Cancer Progression via Maintaining ZEB1 Overexpression by Sponging miR-141/200a.

Authors:  Dandan Li; Jingjie Wang; Meixin Zhang; Xinhui Hu; Jiajun She; Xuemei Qiu; Xudong Zhang; Li Xu; Ying Liu; Shanshan Qin
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-15       Impact factor: 8.886

8.  Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients.

Authors:  Jiarong Cai; Zheng Chen; Xuelian Chen; He Huang; Xia Lin; Bin Miao
Journal:  Biomed Res Int       Date:  2020-09-01       Impact factor: 3.411

9.  LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ.

Authors:  Huaiguo Wu; Juan Gu; Daoping Zhou; Wei Cheng; Yueping Wang; Qingping Wang; Xuedong Wang
Journal:  J Cell Mol Med       Date:  2020-07-11       Impact factor: 5.310

10.  MAGI2-AS3 rs7783388 polymorphism contributes to colorectal cancer risk through altering the binding affinity of the transcription factor GR to the MAGI2-AS3 promoter.

Authors:  Xi Yang; Shenshen Wu; Xiaobo Li; Ying Yin; Rui Chen
Journal:  J Clin Lab Anal       Date:  2020-06-12       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.